N
| Name | Dosage form | ATC code |
|---|---|---|
|
Acetylsalicylic acid Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
500 mg № 10 | N02BA01 |
![]() Alzhmerat Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
600 mg/7 ml № 10 | N07A X02 |
|
Alzhmerat Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
250 mg/ml, 4 ml № 5 | N07AX02 |
|
Amitriptylline Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
25 mg № 50, № 1000 | N06AA09 |
|
Analgin Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
500 mg/ml, 2 ml № 10 | N02BB02 |
|
Analgin for children Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,1 g № 10 | N02BB02 |
|
Analgin for children Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,25 g № 10 | N02BB02 |
|
|
100 mg №50 | N05AH02 |
|
|
25 mg № 50 | N05AH02 |
|
Barviton Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
5 mg/ml, 2 ml № 10 | N06BX18 |
![]() Carbamazepine Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
200 mg №20 | N03AF01 |
![]() Carbamazepine Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
200 mg № 50 | N03AF01 |
![]() Cilityn Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
250 mg/ml, 4 ml № 5, № 10, № 100 | N06BX06 |
![]() Cinnarizine Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,025 g № 25, № 50 | N07CA02 |
![]() Cylityne Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
100 mg, 30 ml | N06BX06 |
|
|
300 mg №100 | N03AX12 |
|
|
300 mg № 20 | N03AX12 |
![]() Ipidacord Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
15 mg/ml 1 ml №10 | N07АА |
![]() Ipidacord Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
5 mg/ml 1 ml №10, №100 | N07АА |
|
|
75 мг №21 | N03A X16 |
|
|
150 мг №21 | N03A X16 |
|
|
300 мг №21 | N03A X16 |
|
|
75 mg №56 | N03A X16 |
|
|
150 mg №56 | N03A X16 |
|
|
300 mg №56 | N03A X16 |
![]() Leknizine Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,025 g № 10, № 50 | N07CA02 |
|
|
200 mg №50 | N03A F01 |
![]() Lidocaine Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
20 mg/ml, 2 ml in ampoules № 10 | N01BB02 |
![]() Lidocaine Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
10 mg/ml, 3,5 ml № 10 | N01BВ02 |
![]() Nalbuphine Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
10 mg/ml 1 ml №10 | N02AF02 |
![]() Nalbuphine Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
10 mg/ml 2 ml №5 | N02AF02 |
![]() Novocaine Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
5 mg/ml, 5 ml № 10 | N01BA02 |
![]() Paracetamol Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
500 mg №10, №20, №50 | N02B E01 |
![]() Piracetam Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
200 mg/mg, 5 ml № 10 | N06BX03 |
![]() Tet 36.6 RAPID with acacia flavour Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
![]() Tet 36.6 RAPID with lemon flavour Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
![]() Tеt 36.6 MAXI with lemon flavour Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BЕ51 |
![]() Tеt 36.6 MAXI with raspberry flavour Pharmacotherapeutic group Agents affecting the nervous system |
23 g № 5, № 10 | N02BE51 |
![]() Tеt 36.6 with acacia flavour Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
13,1 g № 5, № 10 | N02BE51 |
|
Venocor Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
50 mg/ml 2 ml № 10 | N07XX |
|
Venocor Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
50 mg/ml, 5 ml № 5 | N07XX |
![]() Vinpocetin Active ingredient
Pharmacotherapeutic group Agents affecting the nervous system |
0,005 g № 30, № 50 | N06BX18 |
































